Delivery Order SPE2DB24D1205-SPE2DB25FCVDQ

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,713,528 units of the prescription drug Januvia 100 mg tablets. The award has a ceiling value of $14,454.33 and a completion date of February 21, 2024. The contract is a delivery order with a firm fixed price. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,637.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, which is a delivery order, covers the supply of Januvia 100 mg tablets in 90-count packages. The contract has a firm fixed-price pricing type and an ultimate completion date of April 18, 2025. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,680.51 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets in quantities of 1,000. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $3,693.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the procurement of Januvia 100 mg tablets for a period ending on March 20, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,266.66 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 9, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,343,398 units of the drug JANUVIA 100 MG TABLET 1000S. The firm-fixed-price contract has a ceiling value of $15,484.74 and an ultimate completion date of November 6, 2024. This contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,282,117 units of the drug Januvia 100 mg tablets. The fixed-price delivery order, valued at $12,644.69, has a completion date of January 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...
This federal contract award, valued at $11,113.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of JANUVIA 100 MG TABLET 1000S, a pharmaceutical product, over a period ending on January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,969.39 firm fixed-price delivery order is for the supply of 4,567,118,095 units of the drug Januvia 100 mg tablets. The contract has a completion date of February 3, 2025 and was awarded on January 31, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVDQ
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,666,652 units of Januvia 100 mg tablets. The $5,584.65 firm fixed price contract has a performance period ending on March 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and veterans' healthcare systems.

Generated 6/21/25, 9:56 AM